Danaher to buy Cepheid for about $4 billion, including debt

September 6, 2016 11:09 AM

15 0

Danaher Corp said on Tuesday it would buy molecular diagnostics company Cepheid in a deal valued at $4 billion, including debt, to strengthen its diagnostics unit.

Danaher will pay Cepheid $53 per share in cash, a premium of 54 percent to its Friday close of $34.42, and the transaction is expected to close in the fourth quarter.

Also read: China's AgBank posts flat Q3 net profit growth

Read more

To category page